Study to Demonstrate the Maintenance Effect of Treatment and Confirm the Safety of DWP14012 in Patients With Healed Erosive Esophagitis

Condition:   Healed Erosive Esophagitis Interventions:   Drug: DWP14012 X mg;   Drug: DWP14012 Xmg placebo;   Drug: Lansoprazole 15 mg;   Drug: Lansoprazole 15 mg Placebo Sponsor:   Daewoong Pharmaceutical Co. LTD. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials